Skip to content
The Kids Research Institute Australia logo
Donate

Search

Research

Bronchiolitis

Bronchiolitis is a respiratory infection, usually occurring in babies under six months of age. It causes them to wheeze and can lead to pneumonia. Researchers are focusing on vaccines against the virus which commonly causes it.

Elegant mathematical tool could spell the difference for kids globally

A powerful data tool developed by international child development researcher Professor Sally Brinkman and former research assistant Tom Brown could improve early childhood support for children around the world after being launched in Dubai this year.

The immortal legacy of Jette Ford

The Institute farewelled one of its most treasured employees this year, as The Kids Cancer Centre research officer Jette Ford closed the door on a quietly stellar 37-year career which has helped to change the face of cancer research in WA and around the world.

CliniKids puts the ‘evidence’ in evidence-based practice

Autism researchers at The Kids have led the most comprehensive review of the evidence for autism intervention ever compiled

Pooling knowledge: ORIGINS spurs global network

Researchers leading WA’s landmark ORIGINS Project have spearheaded a global network that will see them join forces with similar interventional cohort studies across the world to maximise data collection and learnings for

Leveraging global lung health expertise to help preterm bubs

The world’s leading preterm scientists and doctors have joined forces to help give babies born very prematurely, the best possible life.

Finding the right recipe for youth mental health

In early 2021, The Kids Research Institute Australia researcher Dr Amy Finlay-Jones led a global team in trying to answer that question to help better prioritise mental health spending.

Perseverance pays off for critically ill patients

A legal change fought for by The Kids, consumer advocates, and others within the health sector – and hastened by the COVID-19 crisis – has brought WA into line with the rest of Australia, allowing critically ill or incapacitated patients access to potentially life-saving clinical trials.